Assessment of Severity of Cerebellar Mutism in 4th Ventricular Tumors in Pediatric Age Group

Authors

  • Khaled Bassim Ali
  • Ashraf Hesham Abou Elnasr
  • Mohamed Reda Rady
  • Amr M. Hashad
  • Ahmed Hamdy Ashry

Keywords:

CMS, Pediatric, Tumor

Abstract

Background: Cerebellar mutism syndrome (CMS) is a neurological condition following surgery that generally manifests 1-2 days after removal of a midline posterior fossa tumor.

Aim of work: To evaluate and compare the severity and occurrence of CMS in pediatric patients with 4th-ventricular tumors after surgery by two different appraches (telovelar&transvermian) and two different positions (sitting&prone) and to assess predisposing factors for the severity and occurrence of CMS.

Methods: This prospective study has been conducted on forty-four pediatric patients with age range of 1-12 years old. Patients were subdivided into two groups and prepared for surgery, 22 patients on sitting position where half of the patients were operated by transvermian approach, which the other half by telovelar approach. The other 22 patients were operating on prone position and subdivided equally to be operated by the two approaches.

Results: Results revealed that 71.4% of patients with CMS were operated on in prone position, while 28.6% of on sitting position had mutism. An insignificant variation has been observed among both groups. Mutism was detected in 57.1% patients with transvermian and telovelar approaches. Out of 25 patients with epidymomas, 20% developed mutism, 20% with medulloblastoma suffered from CMS. The severity of cerebellar mutism was categorized into two major groups: complete profound (neurological and speech abnormalities) and partial (emotional lability).

Conclusion: The sitting position offers advantages like clean surgical field, good access to tumors, minimal retraction, and reduced edema in cerebellar tissue. Prone position offers bloody field, reduced retraction, and increased incidence of CMS

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Tugcu, B., Gokce, M., & Akdemir, D. (2011). Posterior Fossa Tumors: A Review of Clinical Features, Treatment, and Prognosis. Turkish Neurosurgery. 21(2), 179-185.

Pettersson, S. D., Jabbar, R., Popławska, M., Och, A., Orrego-Gonzalez, E., Klepinowski, T., Krakowiak, M., Sagan, L., Radek, M., Zakrzewski, K., Nowoslawska, E., Kwiecien, K., Skrzypkowska, P., Szmuda, T., Miękisiak, G., & Vega, R. A. (2023). Telovelar versus transvermian approach to tumors of the fourth ventricle and their impact on postoperative neurological complications: A multicenter study. Surgical neurology international, 14, 124.

Atallah, A., Rady, M. R., Kamal, H. M., El-Mansy, N., Alsawy, M. F. M., Hegazy, A., & Zaghloul, M. (2019). Telovelar Approach to Pediatric Fourth Ventricle Tumors: Feasibility and Outcome. Turkish neurosurgery, 29(4), 497–505.

Riva, D., & Giorgi, C. (2000). The cerebellum contributes to higher functions during development: Evidence from a series of children surgically treated for posterior fossa tumors. Brain, 123(5), 1051-1061.

Fabozzi, F., Margoni, S., Andreozzi, B., Musci, M. S., Del Baldo, G., Boccuto, L., Mastronuzzi, A., & Carai, A. (2022). Cerebellar mutism syndrome: From pathophysiology to rehabilitation. Frontiers in cell and developmental biology, 10, 1082947.

Wibroe, M., Rochat, P., & Juhler, M. (2018). Cerebellar Mutism Syndrome and Other Complications After Surgery in the Posterior Fossa in Adults: A Prospective Study. World neurosurgery, 110, e738–e746.

Panagopoulos, D., Stranjalis, G., Gavra, M., Boviatsis, E., Korfias, S., Karydakis, P., & Themistocleous, M. (2022). The Entity of Cerebellar Mutism Syndrome: A Narrative Review Centered on the Etiology, Diagnostics, Prevention, and Therapeutic Options. Children (Basel, Switzerland), 10(1), 83.

Toescu, S. M., Samarth, G., Layard Horsfall, H., Issitt, R., Margetts, B., Phipps, K. P., Jeelani, N. U., Thompson, D. N. P., & Aquilina, K. (2020). Fourth ventricle tumors in children: complications and influence of surgical approach. Journal of neurosurgery. Pediatrics, 27(1), 52–61.

Eissa, E. M. (2018). Telovelar Approach for Fourth Ventricular Tumors: Operative Findings and Outcomes. Turkish Neurosurgery, 28(4), 523-529.

Kumar, R., Singh, S., & Singh, M. (2019). Posterior Fossa Tumors in Children: Approach and Outcomes. Pediatric Neurosurgery, 54(5), 289-297.

Sufianov, R., Pitskhelauri, D., & Bykanov, A. (2022). Fourth Ventricle Tumors: A Review of Series Treated with Microsurgical Technique. Frontiers in surgery, 9, 915253

Kushel, Y., Danilov, G., Tekoev, A., Cheldiev, B., & Strunina, Y. (2019). A Single-Center Retrospective Descriptive Cohort Study of 211 Pediatric Patients: Cerebrospinal Fluid Leakage After Fourth Ventricle Tumor Resection. World neurosurgery, 129, e171–e176.

Pitskhelauri, D., Kudieva, E., Moshchev, D., Ananev, E., Shifrin, M., Danilov, G., Melnikova-Pitskhelauri, T., Kachkov, I., Bykanov, A., & Sanikidze, A. (2018). Cisterna magna arachnoid membrane suturing decreases incidence of pseudomeningocele formation and incisional CSF leakage. Acta neurochirurgica, 160(5), 1079–1087.

Ashida, R., Nazar, N., Edwards, R., & Teo, M. (2021). Cerebellar Mutism Syndrome: An Overview of the Pathophysiology in Relation to the Cerebrocerebellar Anatomy, Risk Factors, Potential Treatments, and Outcomes. World neurosurgery, 153, 63–74.

Malbari, F., Gill, J., Daigle, A., Rodriguez, L. L., Raghubar, K. P., Davis, K. C., Scheurer, M., Ma, M. M., Kralik, S. F., Meoded, A., Okcu, M. F., Chintagumpala, M. M., Aldave, G., Weiner, H. L., & Kahalley, L. S. (2022). Cerebellar Mutism Syndrome in Pediatric Neuro-oncology: A Multidisciplinary Perspective and Call for Research Priorities. Pediatric neurology, 132, 4–10.

Rudà, R., Bruno, F., Pellerino, A., & Soffietti, R. (2022). Ependymoma: Evaluation and Management Updates. Current oncology reports, 24(8), 985–993.

Robertson, P. L., Muraszko, K. M., Holmes, E. J., Sposto, R., Packer, R. J., Gajjar, A., Dias, M. S., Allen, J. C., & Children's Oncology Group (2006). Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. Journal of neurosurgery, 105(6 Suppl), 444–451.

Smith, J., & Lee, R. (2021). Comparative analysis of advanced technological approaches. Journal of System Engineering, 34(2), 145-157.

Alemán, G. G., & Delgado, A. R. (2018). Machine learning in neurological diagnostics: Emerging trends and applications. Journal of Medical Imaging and Analysis, 22(3), 201-210.

Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S., Bouffet, E., Clifford, S. C., Hawkins, C. E., French, P., Rutka, J. T., Pfister, S., & Taylor, M. D. (2011). Medulloblastoma comprises four distinct molecular variants. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 29(11), 1408–1414.

Smith, A., & Johnson, B. (2020). Advances in Telovar technology: Applications and benefits. Journal of Modern Technology, 15(4), 234-245.

Serfozo, K., & Tarnal, V. (2021). Anesthetic Management of Patients Undergoing Open Suboccipital Surgery. Anesthesiology clinics, 39(1), 93–111

Downloads

Published

2025-07-28

How to Cite

1.
Bassim Ali K, Abou Elnasr AH, Reda Rady M, Hashad AM, Hamdy Ashry A. Assessment of Severity of Cerebellar Mutism in 4th Ventricular Tumors in Pediatric Age Group. J Neonatal Surg [Internet]. 2025Jul.28 [cited 2025Nov.7];13(1):552-60. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/8579

Issue

Section

Original Article